SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+7.49%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$211M
AUM Growth
+$211M
(+2.1%)
Cap. Flow
-$6.65M
Cap. Flow
% of AUM
-3.16%
Top 10 Holdings %
Top 10 Hldgs %
31.01%
Holding
69
New
12
Increased
18
Reduced
24
Closed
9
Top Buys
| 1 |
Cardinal Health
CAH
|
$7.14M |
| 2 |
UnitedHealth
UNH
|
$5.88M |
| 3 |
Thermo Fisher Scientific
TMO
|
$4.97M |
| 4 |
HCA Healthcare
HCA
|
$3.72M |
| 5 |
Elevance Health
ELV
|
$3.49M |
Top Sells
| 1 |
HNT
HEALTH NET INC
HNT
|
$6.74M |
| 2 |
Gilead Sciences
GILD
|
$5.4M |
| 3 |
Humana
HUM
|
$5.36M |
| 4 |
CVS Health
CVS
|
$5.31M |
| 5 |
Cigna
CI
|
$5.12M |
Sector Composition
| 1 | Healthcare | 87.1% |
| 2 | Financials | 2.57% |
| 3 | Energy | 1.89% |
| 4 | Industrials | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
HCA Healthcare
HCA
$94.5B
| $9.47M | 4.5% |
140,000
+55,000
| +65% | +$3.72M |
|
2
Universal Health Services
UHS
$11.6B
| $7.77M | 3.69% |
65,000
+22,778
| +54% | +$2.72M |
|
|
3
Cardinal Health
CAH
$35.5B
| $7.14M | 3.39% |
+80,000
| New | +$7.14M |
|
4
Amgen
AMGN
$155B
| $6.49M | 3.08% |
40,000
| – | – |
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $5.97M | 2.84% |
91,000
+11,600
| +15% | +$761K |
|
|
6
UnitedHealth
UNH
$281B
| $5.88M | 2.79% |
+50,000
| New | +$5.88M |
|
|
7
Cigna
CI
$80.3B
| $5.85M | 2.78% |
40,000
-35,000
| -47% | -$5.12M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.72M | 2.72% |
30,000
+5,000
| +20% | +$954K |
|
9
Boston Scientific
BSX
$156B
| $5.53M | 2.63% |
300,000
+150,000
| +100% | +$2.77M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $5.47M | 2.6% |
17,500
-2,500
| -13% | -$781K |
|
|
AET
11
DELISTED
Aetna Inc
AET
| $5.41M | 2.57% |
50,000
-30,000
| -38% | -$3.24M |
|
12
Bristol-Myers Squibb
BMY
$96B
| $5.16M | 2.45% |
75,000
| – | – |
|
|
13
Thermo Fisher Scientific
TMO
$186B
| $4.97M | 2.36% |
+35,000
| New | +$4.97M |
|
14
McKesson
MCK
$85.4B
| $4.93M | 2.34% |
25,000
-20,000
| -44% | -$3.94M |
|
15
Viatris
VTRS
$12.3B
| $4.87M | 2.31% |
90,000
+30,000
| +50% | +$1.62M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $4.79M | 2.27% |
40,000
-10,000
| -20% | -$1.2M |
|
17
Community Health Systems
CYH
$387M
| $4.38M | 2.08% |
164,900
+43,236
| +36% | +$1.15M |
|
|
HNT
18
DELISTED
HEALTH NET INC
HNT
| $4.22M | 2% |
61,579
-98,421
| -62% | -$6.74M |
|
|
RAD
19
DELISTED
Rite Aid Corporation
RAD
| $4.19M | 1.99% |
535,000
-215,000
| -29% | -$1.69M |
|
|
LHCG
20
DELISTED
LHC Group LLC
LHCG
| $3.97M | 1.89% |
87,705
+20,000
| +30% | +$906K |
|
21
Biogen
BIIB
$19.4B
| $3.83M | 1.82% |
12,500
-7,500
| -38% | -$2.3M |
|
22
Tenet Healthcare
THC
$16.3B
| $3.79M | 1.8% |
125,000
+62,555
| +100% | +$1.9M |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $3.78M | 1.79% |
30,000
-10,000
| -25% | -$1.26M |
|
24
Chemed
CHE
$6.67B
| $3.75M | 1.78% |
25,000
+9,004
| +56% | +$1.35M |
|
|
25
Humana
HUM
$36.5B
| $3.57M | 1.7% |
20,000
-30,000
| -60% | -$5.36M |
|